Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Vascular Cell Function and Arterial Remodeling

Cardiovascular disease is the leading cause of morbidity and mortality in diabetes. Recent clinical studies indicate that sodium-glucose co-transporter 2 (SGLT2) inhibitors improve cardiovascular outcomes in patients with diabetes. The mechanism underlying the beneficial effect of SGLT2 inhibitors i...

Descripción completa

Detalles Bibliográficos
Autores principales: Durante, William, Behnammanesh, Ghazaleh, Peyton, Kelly J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396183/
https://www.ncbi.nlm.nih.gov/pubmed/34445519
http://dx.doi.org/10.3390/ijms22168786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396183/
https://www.ncbi.nlm.nih.gov/pubmed/34445519
http://dx.doi.org/10.3390/ijms22168786

Ejemplares similares